Abstract PL03-01: Working together to identify new epigenetic targets for cancer.

Abstract During my presentation, I will discuss: 1) how we are pooling the expertise and infrastructure of several big pharmas, with the disease and clinical expertise, and patients resources in academia, to accelerate novel target identification; 2) novel epigenetic targets which are worth further exploration; 3) how these efforts are facilitating science and proprietary programmes, including the creation of new biotechs; 4) our plans to establish human disease platforms for novel epigenetic target prioritization. Citation Information: Mol Cancer Ther 2013;12(11 Suppl):PL03-01. Citation Format: Chas Bountra. Working together to identify new epigenetic targets for cancer. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2013 Oct 19-23; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(11 Suppl):Abstract nr PL03-01.